Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,393,621 papers from all fields of science
Search
Sign In
Create Free Account
hammerhead ribozyme
Known as:
ribozyme, hammerhead
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Catalytic RNA
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
2-Selenouridine triphosphate synthesis and Se-RNA transcription
Huiyan Sun
,
Sibo Jiang
,
Julianne Caton-Williams
,
Hehua Liu
,
Zhen Huang
RNA: A publication of the RNA Society
2013
Corpus ID: 16870606
The enzymatic synthesis of 2-selenouridine via 2-selenouridine triphosphate (SeUTP) synthesis and RNA transcription is reported…
Expand
2010
2010
Computational mutagenesis studies of hammerhead ribozyme catalysis.
Tai-Sung Lee
,
D. York
Journal of the American Chemical Society
2010
Corpus ID: 207056675
Computational studies of the mutational effects at the C3, G8, and G5 positions of the hammerhead ribozyme (HHR) are reported…
Expand
2010
2010
Development of a reverse genetics system for a human rabies virus vaccine strain employed in China.
Ying Huang
,
Q. Tang
,
+7 authors
G. Liang
Virus Research
2010
Corpus ID: 43190866
Review
2004
Review
2004
Therapeutic potential of hammerhead ribozymes in the treatment of hyper-proliferative diseases.
G. Grassi
,
P. Dawson
,
G. Guarnieri
,
R. Kandolf
,
M. Grassi
Current Pharmaceutical Biotechnology
2004
Corpus ID: 23991126
The limited efficacy of current therapeutic approaches for a number of socially relevant human diseases such as cancer and…
Expand
Highly Cited
2003
Highly Cited
2003
Diffusely bound Mg2+ ions slightly reorient stems I and II of the hammerhead ribozyme to increase the probability of formation of the catalytic core.
D. Rueda
,
K. Wick
,
S. E. McDowell
,
N. Walter
Biochemistry
2003
Corpus ID: 7204416
The hammerhead ribozyme is one of the best-studied small RNA enzymes, yet is mechanistically still poorly understood. We measured…
Expand
2003
2003
Ribozymes—a snip too far?
D. Lilley
Nature Structural Biology
2003
Corpus ID: 36118320
A recent study demonstrates that, when searching for the smallest active ribozymes, researchers may have thrown away parts that…
Expand
2001
2001
An allele-specific hammerhead ribozyme gene therapy for a porcine model of autosomal dominant retinitis pigmentosa.
L. Shaw
,
A. Skold
,
F. Wong
,
R. Petters
,
Hauswirth Ww
,
Lewin As
Molecular Vision
2001
Corpus ID: 38320125
PURPOSE To develop a hammerhead ribozyme-based gene therapy for a porcine model of autosomal dominant retinitis pigmentosa (ADRP…
Expand
Highly Cited
1999
Highly Cited
1999
High-performance liquid chromatography purification of homogenous-length RNA produced by trans cleavage with a hammerhead ribozyme.
Thomas P. Shields
,
Emilia Mollova
,
Linda STE. Marie
,
Mark R. Hansen
,
Arthur Pardi
RNA: A publication of the RNA Society
1999
Corpus ID: 31071275
An improved method is presented for the preparation of milligram quantities of homogenous-length RNAs suitable for nuclear…
Expand
1996
1996
Delivery of a hammerhead ribozyme specifically down-regulates the production of fibrillin-1 by cultured dermal fibroblasts.
M. Kilpatrick
,
L. Phylactou
,
M. Godfrey
,
C. Wu
,
G. Wu
,
P. Tsipouras
Human Molecular Genetics
1996
Corpus ID: 18874167
The hammerhead ribozyme is a small catalytic RNA molecule. Potential hammerhead ribozymes that possess a catalytic domain and…
Expand
Highly Cited
1994
Highly Cited
1994
Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme.
PS Holm
,
KJ Scanlon
,
M. Dietel
British Journal of Cancer
1994
Corpus ID: 18935858
A major problem in cytostatic treatment of many tumours is the development of multidrug resistance (MDR4). This is most often…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE